The Journal of clinical endocrinology and metabolism
-
J. Clin. Endocrinol. Metab. · Jul 2014
Randomized Controlled Trial Multicenter StudyClinical Trials Express: fracture risk reduction with denosumab in Japanese postmenopausal women and men with osteoporosis: denosumab fracture intervention randomized placebo controlled trial (DIRECT).
Denosumab 60 mg sc injection every 6 months for 36 months was well tolerated and effective in reducing the incidence of vertebral, nonvertebral, and hip fracture in predominantly Caucasian postmenopausal women with osteoporosis. ⋯ These results provide evidence of the efficacy and safety of denosumab 60 mg sc every 6 months in Japanese subjects with osteoporosis.
-
J. Clin. Endocrinol. Metab. · Jul 2014
Randomized Controlled Trial Multicenter StudyTestosterone dose-response relationships with cardiovascular risk markers in androgen-deficient women: a randomized, placebo-controlled trial.
To determine dose-dependent effects of T administration on cardiovascular risk markers in women with low T levels. ⋯ Short-term T administration over a wide range of doses for 24 weeks in women with low T levels was not associated with worsening of cardiovascular risk markers.